Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

FDA clears D3 FastPoint L-DFA influenza A/influenza B virus identification kit

Oct. 30, 2009

AdvanDx receives FDA clearance for its 90-minute E. faecalis test

Oct. 30, 2009

FDA approves assay to aid in the diagnosis of rheumatoid arthritis

Oct. 30, 2009

Prometheus Laboratories launches ProOncDx diagnostic cancer tests in U.S.

Oct. 27, 2009

FDA grants marketing clearance to Axis-Shield's anti-CCP assay in RA

Oct. 27, 2009

Repligen completes patient treatment in phase III RG-1068/MRI imaging trial

Oct. 21, 2009

Epigenomics launches Epi proColon diagnostic blood test for colorectal cancer in Europe

Oct. 20, 2009

TcLand Expression starts study of K-RejX test in kidney transplant recipients at risk of CAMR

Oct. 20, 2009

Transgenomic licenses Cold-PCR technology from Dana-Farber Cancer Institute

Oct. 20, 2009

FDA authorizes Diatherix Laboratories' H1N1-09 influenza test for emergency use

Oct. 20, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...